MedPath

Omega-3 consumption in premenstrual syndrome: measuring its effects on the quality of life using the Premenstrual Symptoms Screening Tool (PSST) and SF12 questionnaire

Not Applicable
Conditions
Premenstrual syndrome.
Pain and other conditions associated with female genital organs and menstrual cycle
Registration Number
IRCT138809212843N1
Lead Sponsor
Tarbiat Modares University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Age 20-35 years, single girls, normal cycle (duration of cycle 22-35, bleeding 3-7 days), normal BMI (18.5-25), PMS according to PSST questionnaire
Exclusion criteria: any history of disease such as hepatic, renal, or respiratory cardiac, diabetes, or respiratory diseases, presence of secondary dysmenorrheal, sea food allergy, use of alcohol, smoking, presence of chronic diseases such as like migraine, use of any drug affecting PMS such as OCP or B6, stressful condition like death of family members

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Premenstrual syndrome (existing symptoms in PSST questionnaire. Timepoint: before intervention, 1, 2, and 3 months after intervention. Method of measurement: PSST questionnaire.;Quality of life. Timepoint: before intervention, 1, 2, and 3 month after intervention. Method of measurement: SF-12 questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath